A GI malignancy refers to any cancerous growth within the gastrointestinal tract. These cancers are often aggressive and can spread quickly if not detected early. Colon cancer, stomach cancer, and pancreatic cancer are common forms of GI malignancy. Gastroenterologists play a vital role in screening for these cancers through procedures like colonoscopies and endoscopies.

Weight-loss injections like Saxenda or Wegovy are available in Turkey as part of weight management programs. These injections help control appetite and promote weight loss by regulating hunger hormones. They are often prescribed to patients with obesity or related health conditions who have not been successful with diet and exercise alone.

Before-and-after images of gastric sleeve patients highlight not only the weight loss but also the excess skin that may remain, especially in areas like the abdomen. Many patients opt for skin removal surgeries after achieving their weight-loss goals.

Diet tablets, or weight-loss pills, are medications or supplements designed to help individuals lose weight by suppressing appetite, boosting metabolism, or blocking fat absorption. Common prescription options include Orlistat and Phentermine, while over-the-counter products often include herbal supplements. However, these should be used under medical supervision, as many come with side effects or limited effectiveness without lifestyle changes.

Wegovy is available through the NHS for patients meeting specific criteria. To qualify, individuals generally need to have a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as diabetes or hypertension. Wegovy is a relatively new option and is prescribed under careful medical supervision.

Wegovy (semaglutide) is a medication that helps with weight loss by mimicking a hormone that regulates appetite. It is prescribed to individuals with obesity or those with weight-related health problems. In the UK, Wegovy has been approved for NHS use for patients who meet certain criteria, providing a non-surgical option for those seeking medical weight-loss assistance.

Sleeve banding combines two bariatric procedures: the gastric sleeve and an adjustable gastric band. It is a less common technique used to enhance the weight-loss results of the sleeve by adding additional restriction through the band. However, complications from the band have made it less favorable in recent years.

Gastric bypass surgery typically costs between £10,000 and £15,000 in private clinics in the UK. This surgery is a popular option for long-term weight loss and involves creating a small stomach pouch and rerouting the intestines to limit food intake and absorption.

A mini gastric sleeve refers to a less invasive version of the standard sleeve gastrectomy. It’s a simpler procedure that results in a smaller stomach size and helps with long-term weight loss. While not as widely performed, it is an option for those seeking weight-loss surgery with fewer complications.

Endoscopic Sleeve Gastroplasty (ESG) is a non-surgical weight-loss procedure where a gastroenterologist uses an endoscope to stitch the stomach into a smaller size, reducing its capacity. Unlike traditional bariatric surgery, ESG is performed through the mouth and doesn’t involve cutting or removing any part of the stomach. Recovery is quicker, and the procedure is reversible, but the weight loss achieved is typically less significant than with RNY or gastric sleeve surgery.

Weight-loss surgery, or bariatric surgery, includes procedures like gastric bypass, sleeve gastrectomy, and gastric banding. These surgeries are recommended for individuals with severe obesity who have not been able to lose weight through diet and exercise alone.

Patients typically need a Body Mass Index (BMI) of 35 or higher, with obesity-related health conditions, or a BMI of 40 or more to qualify for gastric sleeve surgery. This surgery, known as Vertical Sleeve Gastrectomy (VSG), involves removing about 80% of the stomach to reduce food intake and is one of the most popular bariatric procedures.

Semaglutide is a weight-loss medication that mimics a hormone regulating appetite and food intake. In the UK, it is marketed under the brand names Ozempic (for diabetes) and Wegovy (for obesity). It is prescribed to individuals struggling with weight management, often in conjunction with diet and exercise.

An abdominal tumor is any abnormal growth located within the abdomen. Tumors can originate from the stomach, intestines, liver, or other abdominal organs. They can be benign or malignant, and treatment often involves surgery, chemotherapy, or radiation therapy, depending on the tumor's size, type, and stage.

Cancer of the Gastrointestinal Tract (GIT) includes cancers that affect the stomach, intestines, esophagus, colon, liver, and pancreas. Symptoms vary depending on the type of cancer but may include weight loss, blood in the stool, or persistent abdominal pain. Early detection is crucial for improving survival rates, and treatment options range from surgery to chemotherapy and radiation.

The post-op sleeve diet is vital for healing and weight loss after sleeve gastrectomy. It begins with liquids, followed by pureed foods, and eventually includes solid foods. Protein intake is prioritized, and patients must avoid high-fat, high-sugar foods to prevent complications like nausea or dumping syndrome.